NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 47 filers reported holding NEUBASE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $22 | -67.2% | 120,000 | -65.7% | 0.03% | -67.5% |
| Q4 2022 | $67 | -100.0% | 350,000 | -22.2% | 0.08% | -59.8% |
| Q3 2022 | $178,000 | -54.2% | 450,000 | +21.6% | 0.20% | -51.9% |
| Q2 2022 | $389,000 | -36.3% | 370,000 | +13.8% | 0.41% | -19.3% |
| Q1 2022 | $611,000 | +44.8% | 325,000 | +116.7% | 0.51% | +60.8% |
| Q4 2021 | $422,000 | +55.7% | 150,000 | +100.0% | 0.32% | +57.9% |
| Q3 2021 | $271,000 | – | 75,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 470,524 | $494,000 | 0.50% |
| CARNEGIE MELLON UNIVERSITY | 939,412 | $986,000 | 0.50% |
| CM Management, LLC | 370,000 | $389,000 | 0.41% |
| Decheng Capital Management III (Cayman), LLC | 1,000,000 | $1,050,000 | 0.40% |
| Sio Capital Management, LLC | 906,445 | $952,000 | 0.36% |
| AIGH Capital Management LLC | 1,027,585 | $1,079,000 | 0.28% |
| Greenlight Capital | 2,727,027 | $2,863,000 | 0.22% |
| Worth Venture Partners, LLC | 256,553 | $249,000 | 0.15% |
| PERKINS CAPITAL MANAGEMENT INC | 81,500 | $86,000 | 0.09% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $327,000 | 0.01% |